Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcadia Biosciences (RKDA) Return on Capital Employed (2016 - 2025)

Arcadia Biosciences filings provide 11 years of Return on Capital Employed readings, the most recent being 8.88% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed rose 360.0% to 8.88% in Q4 2025 year-over-year; TTM through Dec 2025 was 8.88%, a 360.0% increase, with the full-year FY2025 number at 6.16%, up 435.0% from a year prior.
  • Return on Capital Employed hit 8.88% in Q4 2025 for Arcadia Biosciences, up from 20.84% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 5.83% in Q1 2025 to a low of 63.8% in Q1 2023.
  • Median Return on Capital Employed over the past 5 years was 19.13% (2022), compared with a mean of 25.16%.
  • Biggest five-year swings in Return on Capital Employed: surged 5131bps in 2021 and later crashed -4492bps in 2022.
  • Arcadia Biosciences' Return on Capital Employed stood at 17.18% in 2021, then plummeted by -261bps to 62.09% in 2022, then increased by 29bps to 43.96% in 2023, then soared by 72bps to 12.48% in 2024, then grew by 29bps to 8.88% in 2025.
  • The last three reported values for Return on Capital Employed were 8.88% (Q4 2025), 20.84% (Q3 2025), and 21.5% (Q2 2025) per Business Quant data.